Gamulescu Maria-A, Schalke Berthold, Schuierer Gerhard, Gabel Veit-P
Department of Ophthalmology, University of Regensburg, Germany.
Ann Pharmacother. 2006 Mar;40(3):571-3. doi: 10.1345/aph.1G451. Epub 2006 Feb 28.
To report a case of optic neuritis with visual field defect associated with ibuprofen.
A 41-year-old white man developed blurred vision in his right eye and pain with eye and head movements that lasted 2 days after use of ibuprofen 400 mg 3 times daily during the preceding 3 weeks. Medical and family histories were negative for significant related disease. Ophthalmologic examination revealed a marked decrease in visual acuity to 20/200 in the right eye with quadrant visual field loss and absent responses in visual evoked potential (VEP). After discontinuation of the drug and treatment with high-dose intravenous methylprednisolone and subcutaneous low-molecular-weight heparin, the patient's vision improved to 20/70, the visual field defect vanished, and the VEP returned to almost normal values during a 1 year follow-up period. An objective causality assessment revealed that the adverse reaction was possibly related to ibuprofen.
Ocular toxicity with blurred vision and centrocecal visual field defects have been rarely associated with long-term ibuprofen intake. We report a case of retrobulbar optic neuritis with quadrant visual field defect following short-term but regular ibuprofen intake. Although idiopathic optic neuritis cannot be completely ruled out, the absence of other risk factors and additional findings plus the improvement after discontinuation of the drug speak for isolated toxic optic neuritis of the right eye.
Drug toxicity is an important differential diagnosis in retrobulbar optic neuritis. Clinicians should be aware of the potential optic toxicity, even with short-term use of a drug, and perform a thorough medication history in every patient with visual disturbances without a clear cause.
报告一例与布洛芬相关的伴有视野缺损的视神经炎病例。
一名41岁白人男性,在之前3周内每日3次服用400毫克布洛芬后,右眼出现视力模糊以及眼球和头部运动时疼痛,持续2天。病史和家族史均无显著相关疾病。眼科检查显示右眼视力显著下降至20/200,伴有象限视野缺损,视觉诱发电位(VEP)无反应。停药并接受大剂量静脉注射甲基泼尼松龙和皮下注射低分子量肝素治疗后,在1年的随访期内,患者视力改善至20/70,视野缺损消失,VEP恢复至几乎正常水平。客观因果关系评估显示,该不良反应可能与布洛芬有关。
视力模糊和中心暗点视野缺损的眼部毒性很少与长期服用布洛芬相关。我们报告一例短期规律服用布洛芬后出现伴有象限视野缺损的球后视神经炎病例。尽管不能完全排除特发性视神经炎,但缺乏其他危险因素和额外发现,加上停药后症状改善,提示为右眼孤立性中毒性视神经炎。
药物毒性是球后视神经炎的重要鉴别诊断。临床医生应意识到即使短期使用药物也可能存在潜在的视神经毒性,对于每一位无明确病因的视力障碍患者都应详细询问用药史。